Latest filing published 25 Aug 2026 for NovaBridge Biosciences.
Filing timeline
BuySaleInsider track record
Robert A. Lenz: trading record in brief
This profile gathers the share dealings of Robert A. Lenz across 2 companies, led by Neumora Therapeutics, Inc. and NovaBridge Biosciences. We count 9 filings; the first trade dates from 14 September 2023 and the latest from 22 August 2026.
Sales make up the whole of the open-market record (6 sales, €982k). Besides market trades, the filings include 2 share grants and 1 option exercise.
The latest filing, published on 25 August 2026, reports an option exercise in NovaBridge Biosciences. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert A. Lenz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,218 sharesOrdinary SharesSEC:0001992908-26-000013:0
- 5,614 shares@ US$1.67141.2% of flowCommon StockSEC:0001610717-25-000028:0
- 5,563 shares@ US$15.011210.1% of flowCommon StockSEC:0001610717-24-000505:0
- 30,788 shares@ US$11.814243.5% of flowCommon StockSEC:0001610717-24-000490:0
- 32,948 shares@ US$11.432145.2% of flowCommon StockSEC:0001610717-24-000478:0
- 50,000 shares0Common StockSEC:0001610717-24-000063:0
- 352,941 shares0Common StockSEC:0001610717-23-000286:0
7 of 7 declarations
